CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 162 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2013. The put-call ratio across all filers is 0.83 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $30,000 | +200.0% | 218 | 0.0% | 0.00% | – |
| Q3 2015 | $10,000 | -94.8% | 218 | 0.0% | 0.00% | -100.0% |
| Q2 2015 | $192,000 | -25.6% | 218 | -32.9% | 0.00% | -20.0% |
| Q1 2015 | $258,000 | +16.7% | 325 | -89.2% | 0.01% | 0.0% |
| Q4 2014 | $221,000 | -38.6% | 3,022 | -84.1% | 0.01% | -37.5% |
| Q3 2014 | $360,000 | +221.4% | 19,020 | +4052.8% | 0.01% | +300.0% |
| Q2 2014 | $112,000 | -45.6% | 458 | -92.8% | 0.00% | -60.0% |
| Q1 2014 | $206,000 | -60.8% | 6,391 | -62.1% | 0.01% | -54.5% |
| Q4 2013 | $526,000 | -58.1% | 16,881 | +1288.2% | 0.01% | -60.7% |
| Q3 2013 | $1,255,000 | +486.4% | 1,216 | +88.8% | 0.03% | +460.0% |
| Q2 2013 | $214,000 | – | 644 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TSP Capital Management Group, LLC | 813,273 | $3,286,000 | 1.66% |
| RTW INVESTMENTS, LP | 1,243,164 | $5,022,000 | 1.52% |
| Marcus Capital, LLC | 112,200 | $453,000 | 0.44% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 996,178 | $4,024,000 | 0.29% |
| Benchmark Capital Advisors | 67,000 | $271,000 | 0.20% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 360,299 | $1,456,000 | 0.20% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 2,907,523 | $11,746,000 | 0.15% |
| Virtus ETF Advisers LLC | 59,537 | $241,000 | 0.12% |
| Bellevue Group AG | 160,000 | $646,000 | 0.12% |
| PDT Partners, LLC | 428,300 | $1,730,000 | 0.10% |